Selective point of care nanoprobe breath analyzer

• US 20080077037A1
• Filed: 09/20/2007
• Published: 03/27/2008
• Est. Priority Date: 04/21/2003
• Status: Abandoned Application

• Current Assignee: The Research Foundation for The State University of New York (State University of New York)
• Original Assignee: The Research Foundation for The State University of New York (State University of New York)
• Inventors: Rigas, Anastasia, Gouma, Pelagia-Irene
• Application Number:
  US11/903,135
• Publication Number:
  US 20080077037A1
• Time in Patent Office: Days
• US Class Current: 600/532
• CPC Class Codes: A61B 5/082 Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath A61B5/083, A61B5/091 take precedence
• CPC Class Codes: G01N 33/497 of gaseous biological material, e.g. breath

Abstract

Disclosed is a medical diagnostic device for analyzing breath gases and/or skin emissions, including a highly sensitive sensing component for obtaining an emission concentration profile and a database of breath analysis profiles medical condition characteristics.

Claims

1. An apparatus for analyzing gases in expired breath to assist in diagnosis of a medical condition, the apparatus comprising a nanosensor tuned to a specific concentration profile, to detect a particular gaseous analyte, wherein the presence and/or concentration of said gaseous analyte is indicative of a particular medical condition.

2. The apparatus of claim 1, wherein the nanosensor is constructed of a metal oxide that is not crystalline.

3. The apparatus of claim 1, wherein the nanosensor is an ammonia-specific or ammonia selective nanosensor.

4. The apparatus of claim 1, wherein a plurality of specifically tuned nanosensors can be removably inserted into the apparatus.

5. The apparatus of claim 4, wherein insertion of a second specifically tuned nanosensor allows the apparatus to detect NO gas, insertion of a third specifically tuned nanosensor allows the apparatus to detect another volatile compound present in human breath, and insertion of additional specifically tuned sensors allows the apparatus to detect additional volatile compounds present in human breath.

6. The apparatus of claim 5, wherein the apparatus is a hand-held device that detects NH₃ in expired breath.

7. The apparatus of claim 1, wherein after the subject being evaluated ingests unlabeled urea as a substrate, levels of ammonia are measured in expired breath samples, to establish or rule out a diagnosis of infection with helicobacter pylori.

8. The apparatus of claim 7, wherein the substrate is selectively tuned by spin or drop coating.

9. The apparatus of claim 1, wherein the sensor is tuned to detect NH₃ in expired breath and generates a clear and measurable response for NH₃ concentrations ranging between at least of 50 parts per billion (ppb) and 500 parts per million (ppm).

10. The apparatus of claim 1, wherein presence of a selected gaseous analyte changes electrical resistance of the nanosensor.

11. The apparatus of claim 1, wherein the nanosensor incorporates biomolecule receptors in active, gas sensitive matrices.

12. The apparatus of claim 1, further comprising a baseline database of prior breath emissions for a particular patient.

13. The apparatus of claim 1, wherein the sensing device identifies molecular compounds in expired breath, said molecular compounds including ammonia, nitric oxide, ketones, methane, ethane, butane, pentane, carbon dioxide, carbon monoxide, oxygen, sulfur dioxide, carbon disulfide, hydrogen sulfide, methyl mercaptan, skatole, indole, cadaverine, putrescine, isovaleric acid, trimethylamine, and halogens, isoprene, isoprotanes, prostaglandins and halogen compounds.

14. The apparatus of claim 1, further comprising a baseline database of breath profiles identified as medical condition indicators.

15. The apparatus of claim 1, further comprising a microprocessor capable of identifying a change from a baseline established for a particular patient.

17. The method of claim 15, wherein the sensing electrode is tuned to detect ammonia and/or NH₃ levels.

18. The method of claim 15, wherein volatile components of the breath sample are analyzed to provide a breath profile including both qualitative and quantitative data;

said method further comprising;

comparing the breath profile to a database of breath profiles characteristic of a plurality of medical conditions, to provide information pertinent to diagnosis of the presence or absence of a medical condition.

16. A method for utilizing a concentration profile in a breath sample to assist in the diagnosis of a medical condition, the method comprising:

measuring the concentration profile of a particular gaseous analyte in said breath sample with a nanosensor comprising a sensing electrode containing unlabeled urea as a substrate tuned for measuring said particular gaseous analyte; and

comparing the detected amounts of said gaseous analyte to a baseline to assist in diagnosis of a medical condition.

19. A method for determining biomolecule abundance, the method comprising:

obtaining a breath sample having a plurality of biomolecules; and

analyzing the sample utilizing an encapsulated sensor to determine whether a specific biomolecule in the sample matches a concentration profile of an analyte to which a nanosensor of the sensor tuned.

20. The method of claim 20, wherein the sensor can detect the specific biomolecule at a level of parts per billion.